Department of Bone and Soft Tissue Oncology, Peking University Cancer Hospital, Associate Chief Physician【Specialties】With years of experience in the field of bone and soft‑tissue tumors, he excels at standardized comprehensive treatment for primary benign and malignant bone and soft‑tissue tumors, with particular emphasis on the in‑depth integration of surgical procedures and individualized treatment regimens. He boasts extensive hands‑on experience in surgical interventions during clinical practice. Capable of accurately assessing tumor invasion scope, he develops safe and efficient resection strategies to preserve patients’ limb function to the maximum extent. Meanwhile, he focuses on surgical treatment for malignant melanoma, and has established a complete diagnosis‑and‑treatment system covering precise tumor resection as well as postoperative recurrence prevention and control. In addition, he actively participates in multi‑disciplinary team (MDT) collaboration for oncology cases. He has accumulated distinctive experience in preoperative neoadjuvant chemotherapy, postoperative adjuvant therapy and complication prevention and management for malignant bone tumors. He has taken part in clinical observational studies on chemotherapy for soft‑tissue sarcomas, providing practical evidence for the optimization of treatment protocols.